Biotech IPO Market Hits Turbulence As Several Price Low
After a year of flying high, biotechs are running into trouble this week, as several have priced below their range or pulled the plug on the float entirely, with satiated investor...To view the full article, register now.
Already a subscriber? Click here to view full article